Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim

Generated: March 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018685

« Back to Dashboard

NDA 018685 describes GAVISCON, which is a drug marketed by Sanofi Aventis Us and is included in one NDA. It is available from one supplier. Additional details are available on the GAVISCON profile page.

The generic ingredient in GAVISCON is aluminum hydroxide; magnesium trisilicate. There are one hundred and thirty-four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aluminum hydroxide; magnesium trisilicate profile page.
Summary for 018685
Applicant:Sanofi Aventis Us
Ingredient:aluminum hydroxide; magnesium trisilicate
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 018685
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
GAVISCON aluminum hydroxide; magnesium trisilicate TABLET, CHEWABLE;ORAL 018685 NDA GlaxoSmithKline Consumer Healthcare LP 0135-0096 N 0135-0096-26

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET, CHEWABLE;ORALStrength80MG;20MG
Approval Date:Dec 9, 1983TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:TABLET, CHEWABLE;ORALStrength160MG;40MG
Approval Date:Dec 9, 1983TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
US Army
Chinese Patent Office
Boehringer Ingelheim
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.